Smith & Nephew plc (LON:SN) Insider Sybella Stanley Purchases 3,810 Shares

Smith & Nephew plc (LON:SN) insider Sybella Stanley acquired 3,810 shares of the business’s stock in a transaction dated Wednesday, March 26th. The stock was acquired at an average price of GBX 1,101 ($14.25) per share, for a total transaction of £41,948.10 ($54,294.72).

Smith & Nephew Stock Performance

Shares of LON:SN opened at GBX 1,071 ($13.86) on Friday. The company has a market cap of £11.74 billion, a price-to-earnings ratio of 38.56, a P/E/G ratio of 0.46 and a beta of 0.62. The company has a debt-to-equity ratio of 70.22, a current ratio of 2.51 and a quick ratio of 0.84. The stock has a 50-day moving average price of GBX 1,070.03 and a 200 day moving average price of GBX 1,051.48.

Smith & Nephew Increases Dividend

The company also recently disclosed a dividend, which will be paid on Wednesday, May 28th. Shareholders of record on Thursday, March 27th will be given a dividend of $0.23 per share. The ex-dividend date is Thursday, March 27th. This represents a yield of 1.61%. This is a positive change from Smith & Nephew’s previous dividend of $0.14. Smith & Nephew’s dividend payout ratio (DPR) is currently 104.41%.

Wall Street Analysts Forecast Growth

Separately, JPMorgan Chase & Co. reiterated an “overweight” rating and issued a GBX 1,180 ($15.27) price target on shares of Smith & Nephew in a report on Tuesday, January 14th.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.